Research Alliance Corporation III prices $75 million IPO at $10 per share May 20, 2026 09:00AM
Quince acquires Orphai for LAM-001 drug, raises up to $187 million May 18, 2026 09:27AM
Form SCHEDULE 13G Contineum Therapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P. May 15, 2026 06:41AM
Form SCHEDULE 13G/A Enhabit, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P. May 15, 2026 06:39AM
Form SCHEDULE 13G/A Opus Genetics, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P. May 15, 2026 06:39AM
View Older Stories

May 15, 2026 06:36AM Form SCHEDULE 13G Helix Acquisition Corp. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:33AM Form SCHEDULE 13G Rezolute, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:32AM Form SCHEDULE 13G Ovid Therapeutics Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:31AM Form SCHEDULE 13G CRESCENT BIOPHARMA, INC. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:30AM Form SCHEDULE 13G Camp4 Therapeutics Corp Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:29AM Form SCHEDULE 13G SAB Biotherapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:24AM Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:22AM Form SCHEDULE 13G Talkspace, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:22AM Form SCHEDULE 13G/A Beyond Air, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:22AM Form SCHEDULE 13G Rallybio Corp Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:22AM Form SCHEDULE 13G/A Verastem, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:22AM Form SCHEDULE 13G Nasus Pharma Ltd Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:21AM Form SCHEDULE 13G/A Minerva Neurosciences, Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:21AM Form SCHEDULE 13G TXNM ENERGY INC Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:20AM Form SCHEDULE 13G Korro Bio Ops, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 5, 2026 07:03AM Cellectar Biosciences raises up to $140 million in oversubscribed financing
Apr 27, 2026 07:15AM Sagimet prices $175 million stock offering at $6 per share
Apr 16, 2026 07:00AM Adlai Nortye raises $150 million in private placement financing
Apr 14, 2026 02:08PM Galera and Obsidian merge in $350 million all-stock deal
Apr 14, 2026 08:54AM Obsidian Therapeutics and Galera Therapeutics announce merger with $350M funding
Apr 6, 2026 04:15PM American Integrity Insurance names Brian Foley as CFO
Mar 18, 2026 06:00AM Ovid Therapeutics prices $60 million private placement for drug development
Mar 9, 2026 07:30AM Korro Bio raises $85 million in oversubscribed private placement
Mar 9, 2026 07:05AM Relmada Therapeutics raises $160 million in oversubscribed private placement
Feb 18, 2026 08:01AM Sensei Biotherapeutics acquires Faeth Therapeutics for $200 million
Feb 17, 2026 08:13AM Form SCHEDULE 13G Minerva Neurosciences, Filed by: BALYASNY ASSET MANAGEMENT L.P.
Feb 17, 2026 06:57AM Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Feb 17, 2026 06:49AM Form SCHEDULE 13G/A Arcturus Therapeutics Filed by: BALYASNY ASSET MANAGEMENT L.P.
Feb 17, 2026 06:49AM Form SCHEDULE 13G/A Verastem, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Feb 17, 2026 06:48AM Form SCHEDULE 13G/A Beyond Air, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Feb 17, 2026 06:40AM Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Feb 17, 2026 06:29AM Form SCHEDULE 13G Contineum Therapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P.
Feb 17, 2026 06:28AM Form SCHEDULE 13G Opus Genetics, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Feb 5, 2026 08:01AM LB Pharmaceuticals raises $100 million in private placement
Feb 3, 2026 07:00AM Adlai Nortye raises $140 million in private placement financing
Dec 4, 2025 06:35AM Crescent Biopharma raises $185 million, partners with Kelun-Biotech
Nov 14, 2025 06:10AM Form SCHEDULE 13G/A Verastem, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Nov 14, 2025 06:10AM Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Nov 14, 2025 06:09AM Form SCHEDULE 13G/A Spirit AeroSystems Holdi Filed by: BALYASNY ASSET MANAGEMENT L.P.
Nov 14, 2025 06:09AM Form SCHEDULE 13G/A Lottery.com Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Nov 14, 2025 06:09AM Form SCHEDULE 13G Arcturus Therapeutics Filed by: BALYASNY ASSET MANAGEMENT L.P.
Nov 14, 2025 06:09AM Form SCHEDULE 13G Lottery.com Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Nov 14, 2025 06:09AM Form SCHEDULE 13G/A Camping World Holdings, Filed by: BALYASNY ASSET MANAGEMENT L.P.
Nov 14, 2025 06:09AM Form SCHEDULE 13G/A Beyond Air, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Nov 14, 2025 06:09AM Form SCHEDULE 13G Avalo Therapeutics, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Nov 6, 2025 07:03AM Opus Genetics advances LCA5 gene therapy toward pivotal trial after FDA meeting
Nov 6, 2025 07:01AM Opus Genetics raises $23 million in registered direct offering
Oct 23, 2025 07:25AM Tango Therapeutics raises $225 million in stock offering
Oct 21, 2025 09:00AM Expedia Group names Rob Bevegni as VP of investor relations
Oct 21, 2025 08:00AM Minerva Neurosciences secures up to $200 million for schizophrenia drug trial
View Older Stories